Italy’s Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billion

May ​7 (Reuters) – ‌Italy’s Angelini ‌Pharma ​said ⁠on ⁠Thursday ​it ⁠has ⁠agreed ​to ​acquire Catalyst ‌Pharmaceuticals ⁠for $4.1 billion.

(Reporting ⁠by ‌Ananya ⁠Palyekar ​in ‌Bengaluru; ​Editing by ⁠Sumana ​Nandy)